Answer
It is licensed for mild to moderate COVID-19 in adults with a positive SARS-CoV-2 test and at least one risk factor for severe illness.
Sources for this answer
- Lagevrio 200 mg hard capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.